Associated Papers
Genomic determinants of response and resistance to pirtobrutinib in relapsed/refractory chronic lymphocytic leukemia.
Brown JR et al.
Blood, 2026
41055698 (PubMed )
Supplement: BLOOD_BLD-2024-027009-mmc5.xlsx › Sheet_1
The genomic landscape of Vk*MYC myeloma highlights shared pathways of transformation between mice and humans.
Maura F et al.
Nature Communications, 2024
38714690 (PubMed )
Supplement: 41467_2024_48091_MOESM3_ESM.xlsx › Suppl._Data_4
Genomic landscape and tumor mutational features of resected preinvasive to invasive lung adenocarcinoma.
Lin Y et al.
Frontiers in Oncology, 2024
38803537 (PubMed )
Supplement: Table_1.xlsx › Table_S3
ARF suppression by MYC but not MYCN confers increased malignancy of aggressive pediatric brain tumors.
Mainwaring OJ et al.
Nature Communications, 2023
36869047 (PubMed )
Supplement: 41467_2023_36847_MOESM1_ESM.pdf
Select a paper to view details